Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3514 entries
Sorted by: Best Match Show Resources per page
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074393
Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 01.

UNLABELLED: In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Assessment of Myocardial Viability, an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate technologies are...

Cite
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(16):1-80
(2010). Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ontario health technology assessment series, 10(16), 1-80.
"Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis." Ontario health technology assessment series vol. 10,16 (2010): 1-80.
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 01. PMID: 23074393; PMCID: PMC3377573.
Copy Download .nbib Format: NLM
Nanotechnology: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074489
Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 01.

OBJECTIVE: Due to continuing advances in the development of structures, devices, and systems with a length of about 1 to 100 nanometres (nm) (1 nm is one billionth of a metre), the Medical Advisory Secretariat conducted a horizon scanning...

Cite
Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(19):1-43
(2006). Nanotechnology: an evidence-based analysis. Ontario health technology assessment series, 6(19), 1-43.
"Nanotechnology: an evidence-based analysis." Ontario health technology assessment series vol. 6,19 (2006): 1-43.
Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 01. PMID: 23074489; PMCID: PMC3379172.
Copy Download .nbib Format: NLM
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074389
Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01.

UNLABELLED: In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease (CAD), an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate...

Cite
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38
(2010). Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ontario health technology assessment series, 10(12), 1-38.
"Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis." Ontario health technology assessment series vol. 10,12 (2010): 1-38.
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01. PMID: 23074389; PMCID: PMC3377522.
Copy Download .nbib Format: NLM
Functional brain imaging: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074493
Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 01.

OBJECTIVE: The objective of this analysis is to review a spectrum of functional brain imaging technologies to identify whether there are any imaging modalities that are more effective than others for various brain pathology conditions. This evidence-based analysis reviews...

Cite
Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(22):1-79
(2006). Functional brain imaging: an evidence-based analysis. Ontario health technology assessment series, 6(22), 1-79.
"Functional brain imaging: an evidence-based analysis." Ontario health technology assessment series vol. 6,22 (2006): 1-79.
Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 01. PMID: 23074493; PMCID: PMC3379170.
Copy Download .nbib Format: NLM
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).

European heart journal. Cardiovascular Imaging

Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, Popescu BA, Underwood R, Habib G, Zamorano JL, Saraiva RM, Sabino EC, Botoni FA, Barbosa MM, Barros MVL, Falqueto E, Simões MV, Schmidt A, Rochitte CE, Rocha MOC, Ribeiro ALP, Lancellotti P.
PMID: 29029074
Eur Heart J Cardiovasc Imaging. 2018 Apr 01;19(4):459-460n. doi: 10.1093/ehjci/jex154.

AIMS: To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the non-invasive assessment of patients with Chagas disease, with the intent...

Cite
Nunes MCP, Badano LP, Marin-Neto JA, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459-460ndoi: 10.1093/ehjci/jex154.
Nunes, M. C. P., Badano, L. P., Marin-Neto, J. A., Edvardsen, T., Fernández-Golfín, C., Bucciarelli-Ducci, C., Popescu, B. A., Underwood, R., Habib, G., Zamorano, J. L., Saraiva, R. M., Sabino, E. C., Botoni, F. A., Barbosa, M. M., Barros, M. V. L., Falqueto, E., Simões, M. V., Schmidt, A., Rochitte, C. E., Rocha, M. O. C., Ribeiro, A. L. P., & Lancellotti, P. (2018). Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). European heart journal. Cardiovascular Imaging, 19(4), 459-460n. https://doi.org/10.1093/ehjci/jex154
Nunes, Maria Carmo P, et al. "Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI)." European heart journal. Cardiovascular Imaging vol. 19,4 (2018): 459-460n. doi: https://doi.org/10.1093/ehjci/jex154
Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, Popescu BA, Underwood R, Habib G, Zamorano JL, Saraiva RM, Sabino EC, Botoni FA, Barbosa MM, Barros MVL, Falqueto E, Simões MV, Schmidt A, Rochitte CE, Rocha MOC, Ribeiro ALP, Lancellotti P. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018 Apr 01;19(4):459-460n. doi: 10.1093/ehjci/jex154. PMID: 29029074.
Copy Download .nbib Format: NLM
Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System.

Asian journal of neurosurgery

Thavara BD, Kidangan GS, Rajagopalawarrier B.
PMID: 31143261
Asian J Neurosurg. 2019 Apr-Jun;14(2):453-460. doi: 10.4103/ajns.AJNS_254_18.

BACKGROUND: Conventionally, intradural spinal tumor excision requires longer skin incision, bilateral subperiosteal muscle stripping, and total laminectomy, thereby decreasing the stability of the spine and increasing the morbidity. Minimally invasive surgery (MIS) for intradural spinal tumor excision preserves the...

Cite
Thavara BD, Kidangan GS, Rajagopalawarrier B. Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian J Neurosurg. 2019;14(2):453-460doi: 10.4103/ajns.AJNS_254_18.
Thavara, B. D., Kidangan, G. S., & Rajagopalawarrier, B. (2019). Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian journal of neurosurgery, 14(2), 453-460. https://doi.org/10.4103/ajns.AJNS_254_18
Thavara, Binoy Damodar, et al. "Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System." Asian journal of neurosurgery vol. 14,2 (2019): 453-460. doi: https://doi.org/10.4103/ajns.AJNS_254_18
Thavara BD, Kidangan GS, Rajagopalawarrier B. Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian J Neurosurg. 2019 Apr-Jun;14(2):453-460. doi: 10.4103/ajns.AJNS_254_18. PMID: 31143261; PMCID: PMC6516036.
Copy Download .nbib Format: NLM
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

The Lancet. Neurology

Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS.
PMID: 34687636
Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X.

BACKGROUND: Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, have been proposed as a promising therapeutic option for people with multiple sclerosis on the basis of their immunomodulatory and neuroprotective properties. The MEsenchymal StEm cells for Multiple...

Cite
Uccelli A, Laroni A, Ali R, et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021;20(11):917-929doi: 10.1016/S1474-4422(21)00301-X.
Uccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriot, J., Muraro, P., Nabavi, S. M., Oliveri, R. S., Radue, E., Ramo Tello, C., Schiavetti, I., Sellner, J., Sorensen, P. S., Sormani, M. P., Wuerfel, J. T., Freedman, M. S. (2021). Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. The Lancet. Neurology, 20(11), 917-929. https://doi.org/10.1016/S1474-4422(21)00301-X
Uccelli, Antonio, et al. "Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial." The Lancet. Neurology vol. 20,11 (2021): 917-929. doi: https://doi.org/10.1016/S1474-4422(21)00301-X
Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X. PMID: 34687636.
Copy Download .nbib Format: NLM
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

The Lancet. Neurology

Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS.
PMID: 34687636
Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X.

BACKGROUND: Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, have been proposed as a promising therapeutic option for people with multiple sclerosis on the basis of their immunomodulatory and neuroprotective properties. The MEsenchymal StEm cells for Multiple...

Cite
Uccelli A, Laroni A, Ali R, et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021;20(11):917-929doi: 10.1016/S1474-4422(21)00301-X.
Uccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriot, J., Muraro, P., Nabavi, S. M., Oliveri, R. S., Radue, E., Ramo Tello, C., Schiavetti, I., Sellner, J., Sorensen, P. S., Sormani, M. P., Wuerfel, J. T., Freedman, M. S. (2021). Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. The Lancet. Neurology, 20(11), 917-929. https://doi.org/10.1016/S1474-4422(21)00301-X
Uccelli, Antonio, et al. "Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial." The Lancet. Neurology vol. 20,11 (2021): 917-929. doi: https://doi.org/10.1016/S1474-4422(21)00301-X
Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X. PMID: 34687636.
Copy Download .nbib Format: NLM
Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.

Cardiovascular research

Yu JK, Liang JA, Franceschi WH, Huang Q, Pashakhanloo F, Sung E, Boyle PM, Trayanova NA.
PMID: 33881518
Cardiovasc Res. 2021 Apr 21; doi: 10.1093/cvr/cvab140. Epub 2021 Apr 21.

AIMS: Direct remuscularization with pluripotent stem cell-derived cardiomyocytes (PSC-CMs) seeks to address the onset of heart failure post-myocardial infarction (MI) by treating the persistent muscle deficiency that underlies it. However, direct remuscularization with PSC-CMs could potentially be arrhythmogenic. We...

Cite
Yu JK, Liang JA, Franceschi WH, et al. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models. Cardiovasc Res. 2021;doi: 10.1093/cvr/cvab140.
Yu, J. K., Liang, J. A., Franceschi, W. H., Huang, Q., Pashakhanloo, F., Sung, E., Boyle, P. M., & Trayanova, N. A. (2021). Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models. Cardiovascular research, . https://doi.org/10.1093/cvr/cvab140
Yu, Joseph K, et al. "Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models." Cardiovascular research vol. (2021). doi: https://doi.org/10.1093/cvr/cvab140
Yu JK, Liang JA, Franceschi WH, Huang Q, Pashakhanloo F, Sung E, Boyle PM, Trayanova NA. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models. Cardiovasc Res. 2021 Apr 21; doi: 10.1093/cvr/cvab140. Epub 2021 Apr 21. PMID: 33881518.
Copy Download .nbib Format: NLM
The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes.

Inorganic chemistry

Stemmler AJ, Kampf JW, Kirk ML, Atasi BH, Pecoraro VL.
PMID: 11671025
Inorg Chem. 1999 Jun 14;38(12):2807-2817. doi: 10.1021/ic9800233.

The preparation and characterization of a series of encapsulated-lanthanide 15-metallacrown-5 complexes are reported. Planar ligands such as picoline hydroxamic acid (picha) or nonplanar alpha-amino hydroxamic acids (e.g., glycine hydroxamic acid (glyha)) led to one-step syntheses of metallacrowns in yields...

Cite
Stemmler AJ, Kampf JW, Kirk ML, et al. The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes. Inorg Chem. 1999;38(12):2807-2817doi: 10.1021/ic9800233.
Stemmler, A. J., Kampf, J. W., Kirk, M. L., Atasi, B. H., & Pecoraro, V. L. (1999). The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes. Inorganic chemistry, 38(12), 2807-2817. https://doi.org/10.1021/ic9800233
Stemmler, Ann J., et al. "The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes." Inorganic chemistry vol. 38,12 (1999): 2807-2817. doi: https://doi.org/10.1021/ic9800233
Stemmler AJ, Kampf JW, Kirk ML, Atasi BH, Pecoraro VL. The Preparation, Characterization, and Magnetism of Copper 15-Metallacrown-5 Lanthanide Complexes. Inorg Chem. 1999 Jun 14;38(12):2807-2817. doi: 10.1021/ic9800233. PMID: 11671025.
Copy Download .nbib Format: NLM
Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings.

Journal of medical imaging (Bellingham, Wash.)

Tiwari P, Danish SF, Jiang B, Madabhushi A.
PMID: 26870745
J Med Imaging (Bellingham). 2015 Oct;2(4):041008. doi: 10.1117/1.JMI.2.4.041008. Epub 2015 Sep 25.

Laser interstitial thermal therapy (LITT) has recently emerged as a new treatment modality for cancer pain management that targets the cingulum (pain center in the brain) and has shown promise over radio frequency (RF)-based ablation, due to magnetic resonance...

Cite
Tiwari P, Danish SF, Jiang B, et al. Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings. J Med Imaging (Bellingham). 2015;2(4):041008doi: 10.1117/1.JMI.2.4.041008.
Tiwari, P., Danish, S. F., Jiang, B., & Madabhushi, A. (2015). Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings. Journal of medical imaging (Bellingham, Wash.), 2(4), 041008. https://doi.org/10.1117/1.JMI.2.4.041008
Tiwari, Pallavi, et al. "Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings." Journal of medical imaging (Bellingham, Wash.) vol. 2,4 (2015): 041008. doi: https://doi.org/10.1117/1.JMI.2.4.041008
Tiwari P, Danish SF, Jiang B, Madabhushi A. Association of computerized texture features on MRI with early treatment response following laser ablation for neuropathic cancer pain: preliminary findings. J Med Imaging (Bellingham). 2015 Oct;2(4):041008. doi: 10.1117/1.JMI.2.4.041008. Epub 2015 Sep 25. PMID: 26870745; PMCID: PMC4748210.
Copy Download .nbib Format: NLM
The Diagnostic Accuracy of Magnetic Resonance Imaging for Maternal Acute Adnexal Torsion during Pregnancy: Single-Institution Clinical Performance Review.

Journal of clinical medicine

Lee JH, Roh HJ, Ahn JW, Kim JS, Choi JY, Lee SJ, Lee SH.
PMID: 32668570
J Clin Med. 2020 Jul 13;9(7). doi: 10.3390/jcm9072209.

BACKGROUND: For acute adnexal torsion of pregnant women, appropriate treatment based on an accurate diagnosis is especially important for fertility preservation and timely treatment. The 2017 American College of Obstetricians and Gynecologists (ACOG) Committee Opinion No. 723 announced its...

Cite
Lee JH, Roh HJ, Ahn JW, et al. The Diagnostic Accuracy of Magnetic Resonance Imaging for Maternal Acute Adnexal Torsion during Pregnancy: Single-Institution Clinical Performance Review. J Clin Med. 2020;9(7)doi: 10.3390/jcm9072209.
Lee, J. H., Roh, H. J., Ahn, J. W., Kim, J. S., Choi, J. Y., Lee, S. J., & Lee, S. H. (2020). The Diagnostic Accuracy of Magnetic Resonance Imaging for Maternal Acute Adnexal Torsion during Pregnancy: Single-Institution Clinical Performance Review. Journal of clinical medicine, 9(7), . https://doi.org/10.3390/jcm9072209
Lee, Jong Hwa, et al. "The Diagnostic Accuracy of Magnetic Resonance Imaging for Maternal Acute Adnexal Torsion during Pregnancy: Single-Institution Clinical Performance Review." Journal of clinical medicine vol. 9,7 (2020). doi: https://doi.org/10.3390/jcm9072209
Lee JH, Roh HJ, Ahn JW, Kim JS, Choi JY, Lee SJ, Lee SH. The Diagnostic Accuracy of Magnetic Resonance Imaging for Maternal Acute Adnexal Torsion during Pregnancy: Single-Institution Clinical Performance Review. J Clin Med. 2020 Jul 13;9(7). doi: 10.3390/jcm9072209. PMID: 32668570; PMCID: PMC7408813.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3514 entries